Publications

Skip to content

New and Noteworthy

Explore our latest insights, research, and stories

Flatiron Health announces research to be presented at American Society of Hematology Annual Meeting and Exposition

Real-world evidence
Press releases

Tempus Molecular Profiling Integration now available through Flatiron’s OncoEMR®
- Point of care
Unlocking the power of real-world data across the globe: Recent research accomplishments from Flatiron FORUM and multinational data
- Real-world evidence
- HTA and market access
Real-World Evidence Bolsters Breast Cancer Research at Every Step of the Therapeutic Development Lifecycle

Featured topics

Real-world evidence
Clinical research
Point of care
Flatiron stories
Clinical decision support
Video
Machine learning
Press releases
Post marketing requirements
HTA and market access
Health equity
Case study
EHR-to-EDC

All the latest

Topics

Artificial intelligence

Clinical decision support

Clinical research

DEI

Data management

Drug Discovery

EHR-to-EDC

Flatiron stories

HTA and market access

Health equity

Label expansion

Machine learning

Methodology

Patient identification

Point of Care

Post marketing requirements

Practice management

Precision medicine

Prospective study

Protocol optimization

Real-World Evidence

Regulatory

Site identification

Technology & Engineering

Treatment patterns

Trial design

Unmet need

Value-based care

Content type

Article

Press releases

Case study

Publications

Customer interviews

Event recap

Video

Podcast

Showing 9 of 0 results

Willowglade Technologies and Flatiron Health partner to enhance patient engagement and practice operations
- Point of care
- Press releases
Flatiron Health announces research to be presented at American Society of Hematology Annual Meeting and Exposition
- Real-world evidence
- Press releases
Tempus Molecular Profiling Integration now available through Flatiron’s OncoEMR®
- Point of care
Raleigh-Durham 101: A Candidate’s Guide to Flatiron’s Life Sciences Hub
- Flatiron stories
- Article
A real-world analysis of the relationship between Epstein-Barr Virus positivity and baseline characteristics, treatment patterns and clinical outcomes in diffuse large B-cell lymphoma
ASH Annual Meeting
Design and methodological considerations for real-world data-derived progression-free survival in Multiple Myeloma
ASH Annual Meeting
The impact of structural racism and social determinants of health on fluorescence in situ hybridization testing among patients with multiple myeloma
ASH Annual Meeting
- Publication summary
- Publications
Real-world characteristics and survival outcomes of patients with Mantle Cell Lymphoma treated with covalent Bruton's tyrosine kinase inhibitors in first-line
ASH Annual Meeting
- Publication summary
- Publications
Real-world outcomes of Acute Myeloid Leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2
ASH Annual Meeting
- Publication summary
- Publications

Reimagining the infrastructure of cancer care

Resources
Publications
Company
Media
Careers
Contact Us

Clinical Research
Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Data Confidentiality Commitments
Cookie Settings
© FLATIRON HEALTH® 2024